Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,402,458
+$576,715 QoQ
Shares Held
2,003
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#2,331
of 4,605 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. LLY ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,402,458 | 2,003 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,825,743 | 1,985 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,130,015 | 1,982 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,433,677 | 1,879 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,423,421 | 1,826 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,557,666 | 1,886 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,320,892 | 1,711 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,421,047 | 1,604 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,119,049 | 1,236 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $949,111 | 1,220 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $700,086 | 1,201 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $654,761 | 1,219 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $520,567 | 1,110 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $348,914 | 1,016 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $371,693 | 1,016 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $328,523 | 1,016 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $329,417 | 1,016 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $290,951 | 1,016 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $280,639 | 1,016 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $234,746 | 1,016 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $233,192 | 1,016 | Shares | Sole | 2021-07-16 | |
| 2020-12-31 | $210,881 | 1,249 | Shares | Sole | 2021-01-19 | |
| 2020-06-30 | $211,135 | 1,286 | Shares | Sole | 2020-07-22 | |
| No filing history on record for this holder in this stock. | ||||||